Showing 1641-1650 of 2165 results for "".
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-issues-crl-to-regeneron-for-eylea-hd-extended-dosing/37081/The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoicesOrasis Launches Presbyopia Eye Drop Qlosi
https://modernod.com/podcasts/eyewire-news-the-podcast/orasis-launches-presbyopia-eye-drop-qlosi/37080/A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoicesUtilizing AI to Provide DR Screening to Underserved Communities
https://modernod.com/podcasts/eyewire-news-the-podcast/utilizing-ai-to-provide-dr-screening-to-underserved-communities/37079/EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choice89. Five Years Deep: Optometry Happy Hour Edition
https://modernod.com/podcasts/four-eyes/89-five-years-deep-optometry-happy-hour-edition/37039/In honor of the podcast’s fifth year anniversary, Deepon and Amrit host another popular Happy Hour episode and play an Optometry version of “Have You Ever”. So grab your drink, sit back, and listen as our two hosts go down memory lane of their most wild patient experiences!The Four Eyes Podcast is bHave a Young Patient With Computer Vision Syndrome?
https://modernod.com/articles/significant-findings/have-a-young-patient-with-computer-vision-syndrome/37829/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatHaag-Streit Launches METIS 900 Microscope
https://modernod.com/podcasts/eyewire-news-the-podcast/haag-streit-launches-metis-900-microscope/37074/Haag-Streit launches the METIS 900 ophthalmic microscope system; the FDA accepts Glaukos’ NDA for Epi-on cross-linking; and Optos releases its next generation ultra-widefield SLO imaging technology. Learn more about your ad choices. Visit megaphone.fm/adchoices88. Decoding Headaches: When Vision is the Culprit
https://modernod.com/podcasts/four-eyes/88-decoding-headaches-when-vision-is-the-culprit/37038/Headaches are one of the most common patient complaints—but how do you know if they’re vision-related? In this episode, Dr. Kar and Dr. Bilkhu break down different types of headaches, key signs that point to a visual cause, and when to refer for urgent medical attention. We also dive into treatmentAlcon Voyager DSLT Fully Launched in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-voyager-dslt-fully-launched-in-us/37072/Alcon launches the first DSLT device in thee US; the FDA approves an expanded label for Astellas Pharma's geographic atrophy drug Izervay; and New World Medical received FDA clearance for the VIA360 Surgical System. Learn more about your ad choices. Visit megaphone.fm/adchoicesAAO Opposes NIH Research Funding Proposal
https://modernod.com/podcasts/eyewire-news-the-podcast/aao-opposes-nih-research-funding-proposal/37071/The AAO responds to a proposal by the NIH to limit indirect funding for research projects; Lumenis launches a new device to address lower lid laxity and impaired blinking; and AI Optics receives FDA clearance for a handheld retinal imaging system. Learn more about your ad choices. Visit megaphone.fmFDA Approves Genentech's Susvimo Ocular Implant for DME
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-genentechs-susvimo-ocular-implant-for-dme/37070/The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoices